PHILADELPHIA--(BUSINESS WIRE)--Hemispherx Biopharma, Inc. (AMEX: HEB) announced today that they have enter into an agreement with Armada Health Care to launch their natural interferon, Alferon N Injection® (Alferon®), FDA approved for HPV related genital warts, into Armada’s Specialty Pharmacy infrastructure. Alferon® is the only naturally derived alpha interferon approved in the United States. Studies have indicated Alferon® produces fewer adverse reactions than recombinant alpha interferon, maintains efficacy when an individual’s antibodies may render recombinant interferon ineffective and has higher levels of potency in certain tests. Twenty-two million Americans, according to NIH data, are afflicted by HPV (Human Papillomavirus), for which Alferon® may be indicate in the refractory cases.
